Cytori Reports Third Quarter 2015 Business and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Cytori Reports Third Quarter 2015 Business and Financial Results

Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 3Q15

November 9, 2015 8:40 AM EST

Roth Capital maintained a Buy rating on Cytori Therapeutics, Inc. (NASDAQ: CYTX), and cut the price target of $2.50 (from $4.00), following the company's 3Q15 earnings report. CYTX reported EPS of $0.01 compared with the consensus estimate of ($0.06).

Analyst Joseph Pantginis commented, "With four potential approval... More

Cytori Therapeutics (CYTX) Tops Q3 EPS by 2c

November 5, 2015 5:50 PM EST

Cytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.

... More